Grants provide funding to identify a potential microbial link to Alzheimer’s disease. All awards must be narrowly focused on elucidating the possible roles of infectious agents in the causation of Alzheimer’s disease. The grant awards will support innovative research including basic, clinical and/or non-traditional approaches. This includes proposals that span the breadth of the microbial…
Oct. 15, 2024, 8 a.m. – 5 p.m. PT Lose Angeles, CA The Science of Alzheimer’s & Infectious Diseases Symposium highlights research on the correlation between infectious agents or microbial communities with Alzheimer’s disease and promotes novel research in the field of microbial triggers for Alzheimer’s disease. Presenters will share accomplishments and research outcomes that…
The Infectious Diseases Society of America Foundation recently awarded more than $1.7 million in grant funds to advance novel research into possible links between infectious diseases and the causation of Alzheimer’s disease. The grant funds, which were awarded through the Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program, were dispersed among 11 researchers representing a wide range of research fields and institutions across the U.S. “We’re excited that this grant program has…
In 2019, nearly 80% of U.S. counties had no infectious diseases specialists, leaving too many jurisdictions ill-prepared for the COVID-19 pandemic. The field of HIV medicine faces similar challenges. In 2019, more than 1.2 million people were living with HIV in the U.S., with the need for HIV care outpacing the number of new clinicians entering the field. As the COVID-19 pandemic has demonstrated,…
Three finalists presented their potential innovations during IDWeek 2021 Arlington, VA – Sept. 29, 2021 – The Infectious Diseases Society of America (IDSA) Foundation, in collaboration with Johnson & Johnson Innovation – JLABS (‘JLABS’), recently awarded more than $17,000 in funding through the 2021 IDea Incubator competition to three finalists for their promising innovations aimed at advancing the field of infectious diseases. Sanjay Jain, MD, Filipa Mota, PhD, and Alvaro Ordonez, MD, of Johns Hopkins University took home the top grant of $10,000 for their innovation Molecular Imaging of Bacterial Infections. The…
The IDSA Foundation’s Summer of Science campaign has come to a close, and I’d like to thank each of you for your unwavering support. In 2020, we raised nearly $20,000 toward our match. This year, we wanted to double that number, and thanks to your support, we exceeded our goal! Together we raised $50,000 to support life-saving research, fund the ID…
The IDSA Foundation’s 2021 IDea Incubator in collaboration with Johnson & Johnson Innovation – JLABS (‘JLABS’) offers more than just funding for big ideas in the field of infectious diseases. It provides a platform for sharing your innovation with the ID community and receiving valuable feedback from industry professionals. This year, there’s even more opportunity!…
Alzheimer’s disease affects more than 47 million people worldwide. The effects can be life-changing for both the people who are living with the disease and their loved ones. Although research interest in detecting and treating Alzheimer’s disease has increased, the origins of this complex disease remain a mystery. Intriguing evidence suggests that Alzheimer’s disease may have a link…
Innovation is crucial to helping us solve some of the biggest issues in the field of infectious diseases. That’s why Javeed Siddiqui, MD, MPH, co-founder and chief medical officer of TeleMed2U and long-time supporter of the IDSA Foundation, created the IDea Incubator. The pitch-style competition brings together innovators across all fields and provides an opportunity for them to share their…